We are live on ! Find out more
N

Nuveen Portfolio holdings

AUM $369B
1-Year Est. Return 31.66%
This Fund
S&P 500
This Quarter Est. Return
+10%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$264B
AUM Growth
+$16.6B
Cap. Flow
-$3.28B
Cap. Flow %
-1.24%
Top 10 Hldgs %
18.75%
Holding
3,331
New
118
Increased
1,090
Reduced
1,840
Closed
95

Top Sells

Rank Stock Value
1
CSCO icon
Cisco
CSCO
+$474M
2
CELG
Celgene Corp
CELG
+$421M
3
AVGO icon
Broadcom
AVGO
+$411M
4
NFLX icon
Netflix
NFLX
+$387M
5
AAPL icon
Apple
AAPL
+$372M

Sector Composition

Rank Sector Weight
1 Technology 20.51%
2 Financials 14.64%
3 Healthcare 13.3%
4 Consumer Discretionary 10.29%
5 Communication Services 9.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MSBI icon
2201
Midland States Bancorp
MSBI
$695M
$3.32M ﹤0.01%
114,724
+6,548
+6% +$180K
CNST
2202
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
$3.32M ﹤0.01%
70,476
+29,426
+72% +$850K
SNR
2203
DELISTED
NEW SENIOR INVESTMENT GROUP INC.
SNR
$3.31M ﹤0.01%
354,158
+1,536
+0.4% +$11.4K
PGNX
2204
DELISTED
Progenics Pharmaceuticals Inc
PGNX
$3.31M ﹤0.01%
649,525
+4,835
+0.7% +$25.6K
VEA icon
2205
Vanguard FTSE Developed Markets ETF
VEA
$237B
$3.31M ﹤0.01%
75,000
BRBR icon
2206
BellRing Brands
BRBR
$1.34B
$3.3M ﹤0.01%
+155,075
New +$3.04M
CCF
2207
DELISTED
Chase Corporation
CCF
$3.3M ﹤0.01%
27,860
-1,076
-4% -$125K
YMAB
2208
DELISTED
Y-mAbs Therapeutics
YMAB
$3.3M ﹤0.01%
105,509
+21,254
+25% +$629K
OBK icon
2209
Origin Bancorp
OBK
$1.66B
$3.28M ﹤0.01%
86,686
+8,005
+10% +$281K
AVD icon
2210
American Vanguard Corp
AVD
$68.9M
$3.27M ﹤0.01%
168,127
-15,980
-9% -$251K
VALE icon
2211
Vale
VALE
$62.6B
$3.27M ﹤0.01%
+247,525
New +$2.97M
AD
2212
Array Digital Infrastructure
AD
$3.05B
$3.25M ﹤0.01%
89,841
+17,816
+25% +$624K
SIC
2213
DELISTED
Select Interior Concepts, Inc. Class A Common Stock
SIC
$3.25M ﹤0.01%
361,486
-8,465
-2% -$90.1K
ATEX icon
2214
Anterix
ATEX
$1.94B
$3.24M ﹤0.01%
75,079
-27,680
-27% -$1.13M
UBA
2215
DELISTED
Urstadt Biddle Properties Inc. Class A
UBA
$3.24M ﹤0.01%
130,390
-4,608
-3% -$111K
CDXS icon
2216
Codexis
CDXS
$158M
$3.23M ﹤0.01%
202,086
+16,962
+9% +$251K
GABC icon
2217
German American Bancorp
GABC
$1.9B
$3.23M ﹤0.01%
90,682
-2,254
-2% -$75.4K
WOW
2218
DELISTED
WideOpenWest
WOW
$3.23M ﹤0.01%
435,291
+321,084
+281% +$2.03M
GLOG
2219
DELISTED
GASLOG LTD
GLOG
$3.22M ﹤0.01%
329,226
-13,990
-4% -$159K
DGII icon
2220
Digi International
DGII
$3.1B
$3.22M ﹤0.01%
181,741
+22,423
+14% +$356K
IBN icon
2221
ICICI Bank
IBN
$108B
$3.21M ﹤0.01%
213,055
+2,098
+1% +$28.5K
CRC
2222
DELISTED
California Resources Corporation
CRC
$3.19M ﹤0.01%
353,648
+68,232
+24% +$553K
TXMD icon
2223
TherapeuticsMD
TXMD
$24M
$3.17M ﹤0.01%
26,204
+6,568
+33% +$944K
RPT
2224
Rithm Property Trust
RPT
$93.7M
$3.16M ﹤0.01%
36,864
+16,828
+84% +$1.49M
OIBR.C
2225
DELISTED
OI S.A. American Depositary Shares, each representing five shares of common stock
OIBR.C
$3.16M ﹤0.01%
3,396,332

Similar funds

Nuveen's Q4 2019 Portfolio in Review

As of Q4 2019, Nuveen held 3,331 positions worth $264B, up 6.7% from $247B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Nuveen's Q4 2019 filing shows 118 new, 1,090 increased, 1,840 reduced and 95 closed positions. Its largest new stake was iShares iBoxx $ Investment Grade Corporate Bond ETF: 8,077,161 shares worth $1.03B. The largest sale was Cisco, an estimated $474M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.

  • Nuveen's largest Q4 2019 buy was iShares iBoxx $ Investment Grade Corporate Bond ETF: 8,077,161 shares worth $1.03B.
  • Nuveen added most to Bristol-Myers Squibb in Q4 2019, an estimated $649M increase.
  • Nuveen's biggest Q4 2019 reduction was Cisco, cutting an estimated $474M.
  • Nuveen fully exited Celgene Corp in Q4 2019, selling an estimated $421M.
  • Nuveen's ten largest holdings make up 19% of its $264B portfolio in Q4 2019.
  • Nuveen opened 118 new positions and closed 95 in Q4 2019.
  • Nuveen's portfolio value rose 6.7% quarter-over-quarter to $264B.

Based on Nuveen's 13F filing for Q4 2019, filed 14 Feb 2020.